BTIG maintains Buy rating on Connect Biopharma Hldgs, $5 price target
BTIG maintained a Buy rating on Connect Biopharma Hldgs with a price target of $5.00, implying a 404.0% upside from the previous close.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
BTIG maintained a Buy rating on Connect Biopharma Hldgs with a price target of $5.00, implying a 404.0% upside from the previous close.